November 13, 2023 Bariatric Medicine Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds
October 6, 2023 Bariatric Medicine Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers. Already known but needs context about rarity of some of the side effects versus the beneficial health outcomes when assessing overall risk of its use.
July 6, 2023 Bariatric Medicine Study discusses how BMI should not be the sole indicator of potential health risks when there are other scales like waist circumference that add context to the evaluation.
June 28, 2023 Alternative Medicine TikTokers tout berberine as ‘nature’s Ozempic.’ There is little to no evidence to support this claim.
June 14, 2023 Bariatric Medicine Obesity changes the brain, with ‘no sign of reversibility,’ expert says. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study
May 9, 2023 Bariatric Medicine The claim that semaglutide (Ozempic) leads to temporary hair loss is not a side effect of the drug but a normal physiological response when we lose weight.
March 30, 2023 Bariatric Medicine Limited evidence that COVID -19 infection during pregnancy could lead to a greater risk of childhood obesity. Much more evaluation required to determine is there is a plausible mechanism involved in the process and if this is true.
March 9, 2023 Bariatric Medicine Despite social media buzz, Ozempic is a valuable addition to support people struggling with their weight. It has changed many of my patient’s lives for the better (remission of DM2, fatty liver disease, sleep apnea, osteoarthritic pain, depression…)
March 7, 2023 Bariatric Medicine Many established factors in the calculation of heart disease risk must be considered when interpreting the results of a study that states that the ‘keto-like’ diet may be linked to increasing that risk.
December 19, 2022 Bariatric Medicine Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity